US EditionPublished • loading... • Updated
Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China - AMR Insights
A retrospective study at Jiangxi Cancer Hospital (2019–2024) analyzed bloodstream infections (BSIs) in 954 cancer patients (1,095 episodes, 1,161 isolates). Gram-negative bacteria dominated (62.8%), mainly E. coli (40.9%) and K. pneumoniae (19.1%), while Gram-positives (37.2%) were led by S. aureus (26.2%). Infection patterns varied by cancer type and invasive procedures. High resistance was seen to ampicillin, piperacillin, cefazolin, and eryth…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
